MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.
about
Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cellsThe dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religationSophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakageGenetic events other than BCR-ABL1.Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD.Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127).
P2860
MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
MR-1 blocks the megakaryocytic ...... through MEK dephosphorylation.
@ast
MR-1 blocks the megakaryocytic ...... through MEK dephosphorylation.
@en
type
label
MR-1 blocks the megakaryocytic ...... through MEK dephosphorylation.
@ast
MR-1 blocks the megakaryocytic ...... through MEK dephosphorylation.
@en
prefLabel
MR-1 blocks the megakaryocytic ...... through MEK dephosphorylation.
@ast
MR-1 blocks the megakaryocytic ...... through MEK dephosphorylation.
@en
P2093
P2860
P356
P1433
P1476
MR-1 blocks the megakaryocytic ...... through MEK dephosphorylation.
@en
P2093
P2860
P2888
P356
10.1038/BCJ.2013.5
P577
2013-03-29T00:00:00Z